IN8bio Inc.

AI Score

0

Unlock

0.27
0.00 (0.33%)
At close: Mar 03, 2025, 3:59 PM
0.26
-2.96%
Pre-market: Mar 04, 2025, 04:27 AM EST

IN8bio Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue n/a n/a n/a n/a n/a n/a
Cost of Revenue 2.5M 1.1M 251K 96K 96K 96K
Gross Profit -2.5M -1.1M -251K -96K -96K -96K
Operating Income -30.34M -28.52M -14.65M -8.56M -5.13M -2M
Interest Income n/a n/a n/a n/a n/a n/a
Pretax Income -30.01M -28.52M -14.65M -8.56M -5.13M -2.08M
Net Income -30.01M -27.42M -14.65M -8.56M -5.13M -2.08M
Selling & General & Admin 13.51M 14.46M 7.31M 3.18M 2.71M 1.42M
Research & Development 16.83M 14.06M 7.35M 5.38M 2.36M 581K
Other Expenses n/a n/a n/a n/a n/a -63K
Operating Expenses 30.34M 28.52M 14.65M 8.56M 5.07M 2M
Interest Expense n/a n/a n/a n/a n/a 14K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses 30.34M 28.52M 14.65M 8.56M 5.07M 2M
Income Tax n/a -1.1M 551.44K -118.3K -68K -63K
Shares Outstanding (Basic) 29.86M 20.97M 18.78M 19.35M 19.35M 6.17M
Shares Outstanding (Diluted) 29.86M 20.97M 18.78M 19.35M 19.35M 6.17M
EPS (Basic) -1 -1.31 -0.78 -0.44 -0.27 -0.34
EPS (Diluted) -1 -1.31 -0.78 -0.44 -0.27 -0.34
EBITDA -28.5M -27.42M -14.4M -8.47M -5.04M -1.97M
Depreciation & Amortization 1.83M 1.1M 251K 96K 96K 96K